Expression of peroxisome proliferator-activated receptor gamma and effect of rosuvastatin on thoracic aorta remodeling in spontaneous hypertensive rats

ZHAO Lifang,MIAO Peizhi,LIU Changying,GU Shuiming,XU Yawei

2013-01-01

Abstract:Objective To investigate the expression of peroxisome proliferator-activated receptor gamma(PPAR-γ)and the effect of rosuvastatin on thoracic aorta remodeling in spontaneous hypertensive rat(SHR). Methods Sixteen SHRs were randomly divided into SHR group (n=8) and rosuvastatin(ROS)group (n=8). Eight age-matched male Wistar-Kyoto(WKY)rats were taken as controls.The animals were sacrificed after eight- week treatment.The ratios of media thickness to lumen diameter(MT/LD)and media area to lumen area(MA/ LA)of thoracic aorta were measured by computer image analysis.Serum levels of interleukin-6(IL-6),tumor necrosis factor(TNF)-α,all high sensitivity C-reactive protein(hs-CRP)were detected by ABC-enzyme-linked immunosorbent assay(ELISA).The mRNA and protein expression of thoracic aortic PPAR-γwere detected with real-time-polymerase chain reaction and Western blot,respectively.Results Systolic pressure in 10-and 14- week SHRs were significantly higher than that in 6-week SHRs(both P<0.01).But there was no significant difference in systolic pressure between rats of different ages in both WKY group and ROS group(all P>0.05). Systolic pressure in SHR group were significantly higher than thos in WKY group at the age of 6,10 and 14 weeks (all P<0.01),while systolic pressure in ROS group were significantly lower than that in SHR group at the age of 10 and 14weeks(all P<0.01).Serum levels of IL-6,TNF-αand hs-CRP in SHR group were significantly higherthan those in WKY group and ROS group(all P<0.05),so were MT/LD and MA/LA(all P<0.01).Compared with SHR group,the expression of PPAR-γmRNA and protein of thoracic aorta were significantly increased in ROS group and decreased in WKY group(all P<0.01).Conclusion PPAR-γis likely to be related to vascular remodeling.Rosuvastatin can increase the expression of PPAR-γand improve vascular remodeling so as to inhibit inflammatory reaction in SHRs.